who should not take semaglutide for weight loss The infographic compares 10 commonly discussed weight-loss medicines. Tirzepatide and produce the greatest average loss, but they can cause nausea, vomiting, constipation, gallstones and who can not take semaglutide

In recent years, semaglutide has been approved for use as a weight loss medication under the brand name Wegovy

Ratner RE, Dickey R, Fineman M, et al

According to the NIH Office of Dietary Supplements, absorption issuesnot intake aloneare a leading cause of low B12 levels

What is supported by research

The two diets were obtained from Research Diets (New Jersey, USA): high fat diet (D12492) containing 60 kcal% fat and control diet (D12450B) containing 10 kcal% fat

By Molecule Class, Semaglutide Leads Today but Cedes Leadership by 2035 Semaglutide holds a commanding 58% share of the obesity GLP-1 market in 2025, underpinned by robust clinical validation from the STEPandSELECT trials, proven cardiovascular benefits, and extensive real-world use